Pharmacological management of benign prostatic hyperplasia.
In men with mild to moderate BPH, pharmacotherapy is a safe and effective alternative to surgery. The primary care physician should be able to manage the treatment without referral to a urologist, provided he has undertaken appropriate steps to assure himself, and the patient, that there is no evidence of cancer of the prostate.
Samkange
C
C
Department Institute of Continuing Health Education, University of Zimbabwe, Harare, Zimbabwe.
Bhagat
K
K
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005194:Family Practice / Q000379:methods; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D018579:Patient Selection; D011320:Primary Health Care / Q000379:methods; D011470:Prostatic Hyperplasia / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D012017:Referral and Consultation; D012720:Severity of Illness Index; D014572:Urology
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D018120:Finasteride